Healthcare -
Biotechnology - NASDAQ - US
$ 0.8783
2.56 %
$ 150 M
Market Cap
-2.2
P/E
MCRB - COST OF REVENUE
Cost of Revenue MCRB - Seres Therapeutics, Inc.
704 K
LAST VALUE
-36.25%
2 YEAR CAGR
-62.58%
5 YEAR CAGR
0.00%
10 YEAR CAGR